peroxisome proliferatoractivated receptor delta ppardelta pparbeta also known nuclear hormone receptor nuclear receptor humans encoded ppard gene encodes member peroxisome proliferatoractivated receptor ppar family first identified xenopus ppardelta nuclear hormone receptor governs variety biological processes may involved development several chronic diseases including diabetes obesity atherosclerosis muscle ppard expression increased exercise resulting increased oxidative fatburning capacity increase type ppardelta ampk agonists regarded exercise adipose tissue pparβδ increases oxidation well uncoupling oxidative ppardelta may function integrator transcription repression nuclear receptor signaling activates transcription variety target genes binding specific dna elements well described target genes pparδ include expression gene found elevated colorectal cancer elevated expression repressed adenomatosis polyposis coli apc tumor suppressor protein involved apcbetacatenin signaling pathway knockout studies mice suggested role protein myelination corpus callosum epidermal cell proliferation lipid protein shown involved differentiation lipid directional sensing polarization migration studies role ppardelta cancer produced contradictory results although controversy majority studies suggested ppardelta activation could result changes favorable cancer ppardelta favours tumour ppardelta highly expressed many tissues including colon small intestine liver keratinocytes well heart spleen skeletal muscle lung brain knockout mice lacking ligand binding domain ppardelta viable however mice smaller wild type neo postnatally addition fat stores gonads mutants smaller mutants also display increased epidermal hyperplasia upon induction ppardelta activated cell various fatty acids fatty acid examples naturally occurring fatty acids bind activate ppardelta include arachidonic acid certain members acid family arachidonic acid metabolites including several high affinity ligands ppardelta developed including play important role research one study utilizing ligand shown agonism pparδ changes bodys fuel preference glucose initially ppardelta agonists considered promising therapies exercise mimetic could treat metabolic syndrome later evidence uncovered possible procancer although drug development discontinued due animal studies suggesting increased risk cancer used performance enhancing ppardelta agonists banned peroxisome proliferatoractivated receptor delta shown interact article incorporates text united states national library medicine public domain molecular recognition fatty acids peroxisome proliferatoractivated receptors crystal structure ppar delta complexed human nuclear receptorligand complex human nuclear receptorligand complex human nuclear receptorligand complex molecular recognition fatty acids peroxisome proliferatoractivated receptors isoxazoles novel ppardelta agonists molecular recognition fatty acids peroxisome proliferatoractivated receptors httpsenwikipediaorgwikiperoxisomeproliferatoractivatedreceptordelta